BidaskClub downgraded shares of Hill-Rom Holdings Inc (NYSE:HRC) from a strong-buy rating to a buy rating in a research report released on Monday, July 24th.
A number of other equities analysts also recently commented on HRC. Zacks Investment Research downgraded Hill-Rom Holdings from a buy rating to a hold rating in a research report on Tuesday, July 11th. Morgan Stanley lifted their price objective on Hill-Rom Holdings from $85.00 to $90.00 and gave the company an overweight rating in a research note on Friday, June 30th. ValuEngine raised Hill-Rom Holdings from a hold rating to a buy rating in a research note on Friday, June 2nd. Stifel Nicolaus lifted their price objective on Hill-Rom Holdings from $70.00 to $84.00 and gave the company a buy rating in a research note on Monday, May 1st. Finally, Barclays PLC lifted their price objective on Hill-Rom Holdings from $80.00 to $86.00 and gave the company an overweight rating in a research note on Friday, June 9th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of Buy and an average price target of $88.17.
Shares of Hill-Rom Holdings (HRC) traded up 0.07% on Monday, hitting $75.32. The company had a trading volume of 505,649 shares. The company has a market capitalization of $4.96 billion, a price-to-earnings ratio of 43.89 and a beta of 1.22. The stock’s 50-day moving average is $80.60 and its 200 day moving average is $72.15. Hill-Rom Holdings has a 52 week low of $50.50 and a 52 week high of $84.65.
Hill-Rom Holdings (NYSE:HRC) last issued its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. The company had revenue of $689.10 million for the quarter, compared to analyst estimates of $695.50 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. Hill-Rom Holdings’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period last year, the company earned $0.81 earnings per share. Equities analysts expect that Hill-Rom Holdings will post $3.83 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This report was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://stocknewstimes.com/2017/08/06/bidaskclub-downgrades-hill-rom-holdings-inc-nysehrc-to-buy-updated.html.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 15th will be paid a $0.18 dividend. The ex-dividend date is Thursday, September 14th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.96%. Hill-Rom Holdings’s payout ratio is presently 41.62%.
In related news, SVP Paul Sherwood Johnson sold 2,078 shares of the business’s stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $72.30, for a total transaction of $150,239.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Andreas G. Frank sold 10,660 shares of the business’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total value of $838,089.20. Following the transaction, the senior vice president now directly owns 28,988 shares of the company’s stock, valued at $2,279,036.56. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Independent Portfolio Consultants Inc. boosted its position in Hill-Rom Holdings by 171.5% in the second quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock valued at $107,000 after buying an additional 849 shares during the last quarter. Meadow Creek Investment Management LLC boosted its position in Hill-Rom Holdings by 3.9% in the first quarter. Meadow Creek Investment Management LLC now owns 1,696 shares of the medical technology company’s stock valued at $120,000 after buying an additional 64 shares in the last quarter. Neuburgh Advisers LLC increased its stake in Hill-Rom Holdings by 3.9% in the first quarter. Neuburgh Advisers LLC now owns 2,332 shares of the medical technology company’s stock valued at $165,000 after buying an additional 88 shares during the last quarter. Tyers Asset Management LLC increased its stake in Hill-Rom Holdings by 3.9% in the first quarter. Tyers Asset Management LLC now owns 2,968 shares of the medical technology company’s stock valued at $210,000 after buying an additional 112 shares during the last quarter. Finally, Bancorpsouth Inc. purchased a new stake in Hill-Rom Holdings during the first quarter valued at $210,000. 83.94% of the stock is owned by hedge funds and other institutional investors.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.
